Works matching IS 08876924 AND DT 2007 AND VI 21 AND IP 4

Results: 47

The JAK2V617F mutation is detectable in granulocyte populations at greater than 2 copies per cell among individuals with myeloproliferative disorders.

Published in:

2007

By:

Housni, H E L;
Sidon, P;
Dessars, B;
Heimann, P

Publication type:

Letter

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 805, doi. 10.1038/sj.leu.2404518

By:

Locklin, R. M.;
Croucher, P. I.;
Russell, R. G. G.;
Edwards, C. M.

Publication type:

Article

A novel family of slitrk genes is expressed on hematopoietic stem cells and leukemias.

Published in:

2007

By:

Milde, T.;
Shmelkov, S. V.;
Jensen, K. K.;
Zlotchenko, G.;
Petit, I.;
Rafii, S.

Publication type:

Letter

Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma.

Published in:

2007

By:

Bonvini, P.;
Zorzi, E.;
Basso, G.;
Rosolen, A.

Publication type:

Letter

Unraveling the complex regulation of stem cells: implications for aging and cancer.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 612, doi. 10.1038/sj.leu.2404530

By:

Oakley, E. J.;
Van Zant, G.

Publication type:

Article

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 725, doi. 10.1038/sj.leu.2404531

By:

Schnittger, S.;
Bacher, U.;
Haferlach, C.;
Kern, W.;
Haferlach, T.

Publication type:

Article

Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 764, doi. 10.1038/sj.leu.2404532

By:

Baldwin, B. R.;
Li, L.;
Tse, K. F.;
Small, S.;
Collector, M.;
Whartenby, K. A.;
Sharkis, S. J.;
Racke, F.;
Huso, D.;
Small, D.

Publication type:

Article

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 706, doi. 10.1038/sj.leu.2404535

By:

van der Velden, V. H. J.;
Panzer-Grümayer, E. R.;
Cazzaniga, G.;
Flohr, T.;
Sutton, R.;
Schrauder, A.;
Basso, G.;
Schrappe, M.;
Wijkhuijs, J. M.;
Konrad, M.;
Bartram, C. R.;
Masera, G.;
Biondi, A.;
van Dongen, J. J. M.

Publication type:

Article

IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo.

Published in:

2007

By:

Babbage, G.;
Townsend, M.;
Zojer, N.;
Mockridge, I. C.;
Garand, R.;
Barlogie, B.;
Shaughnessy, Jr., J.;
Stevenson, F. K.;
Sahota, S. S.

Publication type:

Letter

Absence of JAK-2V617F point mutations in multiple myeloma.

Published in:

2007

By:

Huang, Q.;
Li, X.;
Chen, W.;
Weiss, L. M.

Publication type:

Letter

Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38α pathway.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 595, doi. 10.1038/sj.leu.2404540

By:

Dassé, E.;
Bridoux, L.;
Baranek, T.;
Lambert, E.;
Salesse, S.;
Sowa, M. L.;
Martiny, L.;
Trentesaux, C.;
Petitfrère, E.

Publication type:

Article

A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome.

Published in:

2007

By:

La Starza, R.;
Rosati, R.;
Roti, G.;
Gorello, P.;
Bardi, A.;
Crescenzi, B.;
Pierini, V.;
Calabrese, O.;
Baens, M.;
Folens, C.;
Cools, J.;
Marynen, P.;
Martelli, M. F.;
Mecucci, C.;
Cuneo, A.

Publication type:

Letter

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 697, doi. 10.1038/sj.leu.2404544

By:

Ricca, I.;
Rocci, A.;
Drandi, D.;
Francese, R.;
Compagno, M.;
Lobetti Bodoni, C.;
De Marco, F.;
Astolfi, M.;
Monitillo, L.;
Vallet, S.;
Calvi, R.;
Ficara, F.;
Omedè, P.;
Rosato, R.;
Gallamini, A.;
Marinone, C.;
Bergui, L.;
Boccadoro, M.;
Tarella, C.;
Ladetto, M.

Publication type:

Article

A phase II study of temozolomide therapy for poor-risk patients aged >or=60 years with acute myeloid leukemia: low levels of MGMT predict for response.

Published in:

2007

By:

Brandwein, J. M.;
Yang, L.;
Schimmer, A. D.;
Schuh, A. C.;
Gupta, V.;
Wells, R. A.;
Alibhai, S. M. H.;
Xu, W.;
Minden, M. D.

Publication type:

clinical trial

The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines.

Published in:

2007

By:

Medeiros, B. C.;
Landau, H. J.;
Morrow, M.;
Lockerbie, R. O.;
Pitts, T.;
Eckhardt, S. G.

Publication type:

journal article

Reply to ‘Absence of JAK-2 (Val617Phe) point mutations in multiple myeloma’ by Dr Qin Huang et al. referred to ‘Screening of JAK2 V617F mutation in multiple myeloma’ from Fiorini A et al. published in Leukemia 2006, October 20.

Published in:

2007

By:

Fiorini, A.;
Farina, G.;
Reddiconto, G.;
Palladino, M.;
Rossi, E.;
Za, T.;
Laurenti, L.;
Giammarco, S.;
Chiusolo, P.;
Leone, G.;
Sica, S.

Publication type:

Letter

Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 732, doi. 10.1038/sj.leu.2404556

By:

Bringmann, A.;
Schmidt, S. M.;
Weck, M. M.;
Brauer, K. M.;
von Schwarzenberg, K.;
Werth, D.;
Grünebach, F.;
Brossart, P.

Publication type:

Article

The tyrosine-kinase inhibitor imatinib induces long-term remission in a patient with chronic myelogenous leukemia with translocation t(4;22).

Published in:

2007

By:

Neumann, F.;
Poelitz, A.;
Hildebrandt, B.;
Fenk, R.;
Haas, R.;
Royer-Pokora, B.;
Germing, U.

Publication type:

Letter

Rituximab in CD20 positive multiple myeloma.

Published in:

2007

By:

Moreau, P.;
Voillat, L.;
Benboukher, L.;
Mathiot, C.;
Dumontet, C.;
Robillard, N.;
Hérault, O.;
Garnache, F.;
Garand, R.;
Varoqueaux, N.;
Avet-Loiseau, H.;
Harousseau, J. L.;
Bataille, R.

Publication type:

Letter

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 627, doi. 10.1038/sj.leu.2404562

By:

Hedenus, M.;
Birgegård, G.;
Näsman, P.;
Ahlberg, L.;
Karlsson, T.;
Lauri, B.;
Lundin, J.;
Lärfars, G.;
Österborg, A.

Publication type:

Article

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 754, doi. 10.1038/sj.leu.2404563

By:

Pike-Overzet, K.;
de Ridder, D.;
Weerkamp, F.;
Baert, M. R. M.;
Verstegen, M. M. A.;
Brugman, M. H.;
Howe, S. J.;
Reinders, M. J. T.;
Thrasher, A. J.;
Wagemaker, G.;
van Dongen, J. J. M.;
Staal, F. J. T.

Publication type:

Article

A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 668, doi. 10.1038/sj.leu.2404564

By:

Verburgh, E.;
Achten, R.;
Louw, V. J.;
Brusselmans, C.;
Delforge, M.;
Boogaerts, M.;
Hagemeijer, A.;
Vandenberghe, P.;
Verhoef, G.

Publication type:

Article

Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells.

Published in:

2007

By:

Janz, M.;
Stühmer, T.;
Vassilev, L. T.;
Bargou, R. C.;
Stühmer, T

Publication type:

journal article

Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion.

Published in:

2007

By:

Huang, X. j.;
Zhao, X. y.;
Liu, D. h.;
Liu, K. y.;
Xu, L. p.

Publication type:

Letter

The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders.

Published in:

2007

By:

Hammond, E.;
Shaw, K.;
Herrmann, R.

Publication type:

Letter

“The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders”, by El Housni et al.

Published in:

2007

By:

Hammond, E.;
Shaw, K.;
Herrmann, R.

Publication type:

Letter

The JAK2V617F mutation is detectable in granulocyte populations at greater than 2 copies per cell among individuals with myeloproliferative disorders.

Published in:

2007

By:

Housni, H. E. L.;
Sidon, P.;
Dessars, B.;
Heimann, P.

Publication type:

Letter

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 678, doi. 10.1038/sj.leu.2404571

By:

Matsuda, A.;
Germing, U.;
Jinnai, I.;
Iwanaga, M.;
Misumi, M.;
Kuendgen, A.;
Strupp, C.;
Miyazaki, Y.;
Tsushima, H.;
Sakai, M.;
Bessho, M.;
Gattermann, N.;
Aul, C.;
Tomonaga, M.

Publication type:

Article

A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia.

Published in:

2007

By:

Marinelli, A.;
Bossi, D.;
Pelicci, P. G.;
Minucci, S.

Publication type:

journal article

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide.

Published in:

2007

By:

Prince, H. M.;
Schenkel, B.;
Mileshkin, L.

Publication type:

Letter

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin.

Published in:

2007

By:

Durie, B. G. M.;
Rajkumar, S. V.

Publication type:

Letter

Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 651, doi. 10.1038/sj.leu.2404575

By:

Chiang, E. P.;
Wang, Y. C.;
Tang, F. Y.

Publication type:

Article

Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional status.

Published in:

2007

By:

Alibhai, S. M. H.;
Leach, M.;
Kowgier, M. E.;
Tomlinson, G. A.;
Brandwein, J. M.;
Minden, M. D.

Publication type:

Letter

Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The ‘big sister’ of the infant disease?

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 642, doi. 10.1038/sj.leu.2404577

By:

Mann, G.;
Cazzaniga, G.;
van der Velden, V. H. J.;
Flohr, T.;
Csinady, E.;
Paganin, M.;
Schrauder, A.;
Dohnal, A. M.;
Schrappe, M.;
Biondi, A.;
Gadner, H.;
van Dongen, J. J. M.;
Panzer-Grümayer, E. R.

Publication type:

Article

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.

Published in:

2007

By:

Jansen, M. W. J. C.;
Corral, L.;
van der Velden, V. H. J.;
Panzer-Grümayer, R.;
Schrappe, M.;
Schrauder, A.;
Marschalek, R.;
Meyer, C.;
den Boer, M. L.;
Hop, W. J. C.;
Valsecchi, M. G.;
Basso, G.;
Biondi, A.;
Pieters, R.;
van Dongen, J. J. M.;
Panzer-Grümayer, R

Publication type:

journal article

A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia.

Published in:

2007

By:

Reader, J. C.;
Meekins, J. S.;
Gojo, I.;
Ning, Y.

Publication type:

Letter

A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia.

Published in:

2007

By:

van der Velden, V. H. J.;
Beverloo, H. B.;
Hoogeveen, P. G.;
Zwaan, Ch. M.

Publication type:

Letter

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 747, doi. 10.1038/sj.leu.2404583

By:

Hu, H. M.;
Kanda, K.;
Zhang, L.;
Boxer, L. M.

Publication type:

Article

HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 788, doi. 10.1038/sj.leu.2404585

By:

Akl, H.;
Badran, B. M.;
Zein, N. E.;
Bex, F.;
Sotiriou, C.;
Willard-Gallo, K. E.;
Burny, A.;
Martiat, P.

Publication type:

Article

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 604, doi. 10.1038/sj.leu.2404586

By:

van der Velden, V. H. J.;
Cazzaniga, G.;
Schrauder, A.;
Hancock, J.;
Bader, P.;
Panzer-Grumayer, E. R.;
Flohr, T.;
Sutton, R.;
Cave, H.;
Madsen, H. O.;
Cayuela, J. M.;
Trka, J.;
Eckert, C.;
Foroni, L.;
zur Stadt, U.;
Beldjord, K.;
Raff, T.;
van der Schoot, C. E.;
van Dongen, J. J. M.

Publication type:

Article

Highly purified CD38+ and CD38− sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 687, doi. 10.1038/sj.leu.2404587

By:

Pepper, C.;
Ward, R.;
Lin, T. T.;
Brennan, P.;
Starczynski, J.;
Musson, M.;
Rowntree, C.;
Bentley, P.;
Mills, K.;
Pratt, G.;
Fegan, C.

Publication type:

Article

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 659, doi. 10.1038/sj.leu.2404590

By:

Epling-Burnette, P. K.;
Painter, J. S.;
Rollison, D. E.;
Ku, E.;
Vendron, D.;
Widen, R.;
Boulware, D.;
Zou, J. X.;
Bai, F.;
List, A. F.

Publication type:

Article

High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 780, doi. 10.1038/sj.leu.2404594

By:

Renné, C.;
Willenbrock, K.;
Martin-Subero, J. I.;
Hinsch, N.;
Döring, C.;
Tiacci, E.;
Klapper, W.;
Möller, P.;
Küppers, R.;
Hansmann, M. L.;
Siebert, R.;
Bräuninger, A.

Publication type:

Article

Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia.

Published in:

2007

By:

Pui, C.-H.;
Campana, D.

Publication type:

Editorial

Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis.

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 797, doi. 10.1038/sj.leu.2404599

By:

Ramirez, J. M.;
Ocio, E. M.;
San Miguel, J. F.;
Pandiella, A.

Publication type:

Article

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

Published in:

Leukemia (08876924), 2007, v. 21, n. 4, p. 622, doi. 10.1038/sj.leu.2404603

By:

Szczepański, T.

Publication type:

Article

The Hippocratic treatise 'On glands': the first document on lymphoid tissue and lymph nodes.

Published in:

2007

By:

Crivellato, E.;
Travan, L.;
Ribatti, D.

Publication type:

Biography